One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Important lessons on healthcare from rare diseases
doi : 10.1016/S1474-4422(24)00136-4
Volume 23, Issue 5, May 2024, Page 447
Fluctuations in Parkinson's disease: progress and challenges
doi : 10.1016/S1474-4422(24)00116-9
Volume 23, Issue 5, May 2024, Pages 448-449
A disease-specific therapy in facioscapulohumeral muscular dystrophy
doi : 10.1016/S1474-4422(24)00129-7
Volume 23, Issue 5, May 2024, Pages 449-451
Association of Pick's disease with the MAPT H2 haplotype
doi : 10.1016/S1474-4422(24)00123-6
Volume 23, Issue 5, May 2024, Pages 451-453
Insights into the progression of genetic Alzheimer's disease from tau PET
doi : 10.1016/S1474-4422(24)00124-8
Volume 23, Issue 5, May 2024, Pages 453-454
Surrogate endpoints for progressive multifocal leukoencephalopathy
doi : 10.1016/S1474-4422(24)00132-7
Volume 23, Issue 5, May 2024, Pages 455-456
Factors affecting brain maturation trajectories in early childhood
doi : 10.1016/S1474-4422(24)00089-9
Volume 23, Issue 5, May 2024, Pages 456-458
The need for partnerships in migration for medical workers
doi : 10.1016/S1474-4422(24)00117-0
Volume 23, Issue 5, May 2024, Page 459
The African Stroke Organization Conference 2023
doi : 10.1016/S1474-4422(24)00139-X
Volume 23, Issue 5, May 2024, Pages 459-460
Dementia prevention: from idealism to realism
doi : 10.1016/S1474-4422(24)00133-9
Volume 23, Issue 5, May 2024, Page 460
Correction to Lancet Neurol 2024; 23: 344–81
doi : 10.1016/S1474-4422(24)00114-5
Volume 23, Issue 5, May 2024, Page e9
Felicia Bliss Axelrod: the dysautonomia pioneer
doi : 10.1016/S1474-4422(24)00131-5
Volume 23, Issue 5, May 2024, Page 461
Fostering diversity, equity, and inclusion in Europe
doi : 10.1016/S1474-4422(24)00126-1
Volume 23, Issue 5, May 2024, Page 462
A neurotransmitter with a fascinating story
doi : 10.1016/S1474-4422(24)00138-8
Volume 23, Issue 5, May 2024, Page 464
Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
doi : 10.1016/S1474-4422(24)00052-8
Volume 23, Issue 5, May 2024, Pages 465-476
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial
doi : 10.1016/S1474-4422(24)00073-5
Volume 23, Issue 5, May 2024, Pages 477-486
MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
doi : 10.1016/S1474-4422(24)00083-8
Volume 23, Issue 5, May 2024, Pages 487-499
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study
doi : 10.1016/S1474-4422(24)00084-X
Volume 23, Issue 5, May 2024, Pages 500-510
Improving epilepsy diagnosis across the lifespan: approaches and innovations
doi : 10.1016/S1474-4422(24)00079-6
Volume 23, Issue 5, May 2024, Pages 511-521
Complex regional pain syndrome: advances in epidemiology, pathophysiology, diagnosis, and treatment
doi : 10.1016/S1474-4422(24)00076-0
Volume 23, Issue 5, May 2024, Pages 522-533
Biomarkers for progressive multifocal leukoencephalopathy: emerging data for use of JC virus DNA copy number in clinical trials
doi : 10.1016/S1474-4422(24)00099-1
Volume 23, Issue 5, May 2024, Pages 534-544
